The stock market has faced significant turmoil recently, with the S&P 500 suffering its worst performance in 2025 so far. Despite widespread losses across sectors, healthcare has emerged as a strong performer. Novo Nordisk (NYSE: NVO), a high-quality pharmaceutical company, has caught the spotlight after its stock price dipped to 52-week lows.